MAPT and dementia: The tau protein, despite its lower sensitivity and specificity, may be an alternative marker to YKL-40 in the diagnosis of early stages of dementia, especially for patients in whom the concentration of YKL-40 is elevated for other reasons, such as chronic inflammatory diseases.